NCT05631938View on ClinicalTrials.gov

Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

September 4, 2023

Study Completion Date

September 4, 2023

Conditions
Renal Impairment
Interventions
DRUG

cytisinicline

film-coated oral tablets containing 3 mg cytisinicline

Trial Locations (6)

28006

Hospital Universitario de La Princessa, Madrid

28040

Hospital Clínico San Carlos, Madrid

28046

Hospital Universitario La Paz, Madrid

4710-243

Hospital de Braga, Centro Clínico Académico Braga, Associação, Braga

4250-449

BlueClinical Phase I, Porto

Porto District

"Early Phase Clinical Trials Unit , CHVNG/E + BlueClinical"

Sponsors
All Listed Sponsors
lead

Achieve Life Sciences

INDUSTRY